Although the experimental approach only used one dose of both OEA and POEA, the data suggest that both compounds were almost equal in the normalization of the diet-induced obesity metabolic disruptions, although OEA was apparently more efficient in reducing liver fat content or inhibiting the lipogenic enzyme FAS. The gene discussed is FAS; the disease is Obesity.